Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02428855 |
|---|---|
| Brief Title: | Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma |
| First Submitted : | April 23, 2015 |
| First Submitted that Met QC Criteria : | April 28, 2015 |
| First Posted : | April 29, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 23, 2018 |
| Last Update Posted : | April 24, 2018 |